ASTRAZENECA PHARMACEUTICALS LP
Lobbying client. Federal LDA filings.
- Source id
193505- General description
- Biopharmaceutical Company.
- State
- DE
- Country
- US
- Principal place of business
- US
- Government-entity client
- false
- Effective date
- 2014-01-01
- Total spend (across 1 ingested filings)
- $80,000
Filings (1) — $80,000
| Posted | Type | Year | Lobbying firm | Income |
|---|---|---|---|---|
| 2026-04-20 | Q1 | 2026 | W STRATEGIES, LLC | $80,000 |
Connected on the graph
12 typed relationships in the influence graph — 12 inbound, 0 outbound, grouped by type.
lobbied for (12)
| date | dir | entity | amount | role | source |
|---|---|---|---|---|---|
| — | ← | Sarah Cudworth Arbes | — | lda_lobbyist_client | |
| — | ← | Art Motta | — | lda_lobbyist_client | |
| — | ← | Caroline Quat | — | lda_lobbyist_client | |
| — | ← | Ted Lehman | — | lda_lobbyist_client | |
| — | ← | Daniel M Todd | — | lda_lobbyist_client | |
| — | ← | Lisa Langenderfer | — | lda_lobbyist_client | |
| — | ← | Eric Bergren | — | lda_lobbyist_client | |
| — | ← | Emily Mace | — | lda_lobbyist_client | |
| — | ← | Katie Jones | — | lda_lobbyist_client | |
| — | ← | Katherine Fleming Cotton | — | lda_lobbyist_client | |
| — | ← | Darren Willcox | — | lda_lobbyist_client | |
| — | ← | Paul Edattel | — | lda_lobbyist_client |